Propofol-remifentanil patient-controlled sedation for endoscopic procedures: a prospective service audit
Authors' conclusion
The results from our prospective service audit indicate that propofol-remifentanil patient-controlled sedation is a safe and reliable technique in patients undergoing endoscopic procedures.
Study context
- Population
- Patients referred for endoscopy after failure under endoscopist-administered sedation, refusal without general anesthesia (GA), or planned complex procedure, 2017–2021
- Participants
- 670 procedures
- Outcome
- Adequacy of sedation (Modified Gloucester Scale) and patient satisfaction
Main finding
As reported in the abstract
Adequacy of sedation and patient satisfaction
- All procedures accomplished with adequate sedation without need for ventilation or GA
- 670
Observational data: associations, not effects.
Safety
Adverse events (Tracking and Reporting Outcomes of Procedural Sedation)
- Sentinel airway or respiratory events
- 0
- Airway obstruction requiring simple airway maneuver
- 19/670 (2.8%)
- Average body mass index (BMI) in patients with airway obstruction (documented in 18/19)
- 35 kg·m-2
- Self-terminating apnea
- 7/670 (1%)
- Vomiting
- 3/670 (0.4%)
- Aspiration
- 0
- Vasopressor required to maintain BP within 20% of preprocedure values
- 17/665 (2.6%)
Original publication
Propofol-remifentanil patient-controlled sedation for endoscopic procedures: a prospective service audit. Can J Anaesth. Published 9 October 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →